title: Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole.
authors.forename: Marc
authors.initials: M
authors.lastname: De Hert
authors.forename: Linda
authors.initials: L
authors.lastname: Hanssens
authors.forename: Ruud
authors.initials: R
authors.lastname: van Winkel
authors.forename: Martien
authors.initials: M
authors.lastname: Wampers
authors.forename: Dominique
authors.initials: D
authors.lastname: Van Eyck
authors.forename: Andre
authors.initials: A
authors.lastname: Scheen
authors.forename: Joseph
authors.initials: J
authors.lastname: Peuskens
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D000068180:Aripiprazole; D003920:Diabetes Mellitus / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole